national trends in statin use by coronary heart disease risk category国家趋势的他汀类药物使用冠状动脉心脏病的风险类别.pdfVIP

national trends in statin use by coronary heart disease risk category国家趋势的他汀类药物使用冠状动脉心脏病的风险类别.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
national trends in statin use by coronary heart disease risk category国家趋势的他汀类药物使用冠状动脉心脏病的风险类别

Open access, freely available online PLoS MEDICINE National Trends in Statin Use by Coronary Heart Disease Risk Category 1 1 2 1* Jun Ma , Niraj L. Sehgal , John Z. Ayanian , Randall S. Stafford 1 Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, United States of America, 2 Division of General Medicine, Brigham and Women’s Hospital and Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America Competing Interests: The authors A B S T R A C T have declared that no competing interests exist. Background Author Contributions: JM, NLS, and RSS designed the study. JM, Only limited research tracks United States trends in the use of statins recorded during NLS, and RSS analyzed the data. JM, JZA, NLS, and RSS contributed outpatient visits, particularly use by patients at moderate to high cardiovascular risk. to writing the paper. Academic Editor: Helen Colhoun, Methods and Findings University College Dublin, Ireland Data collected between 1992 and 2002 in two federally administered surveys provided Citation: Ma J, Sehgal NL, Ayanian national estimates of statin use among ambulatory patients, stratified by coronary heart disease JZ, Stafford RS (2005) National risk based on risk factor counting and clinical diagnoses. Statin use grew from 47% of all lipid- trends in statin use by coronary heart disease risk category. PLoS lowering medications in 1992 to 87% in 2002, with atorvastatin being the leading medication in Med 2(5): e123. 2002. Statin use by patients with hyperlipidemia, as

您可能关注的文档

文档评论(0)

hello118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档